How the Gene Editing Market is Positioned for Growth: Trends, Market Size, and Future Opportunities (2025-2034)
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theGene Editing Market?
The increased instances of communicable diseases are driving the growth of the gene editing market, as these editing techniques become critical in diagnosing and curing them. Infectious agents like bacteria, viruses, or parasites cause communicable diseases, which are transmissible from person to person, animals, or the environment. The increasing application of gene editing technologies aids in creating targeted strategies to identify and neutralize pathogens at the genetic level, thus augmenting disease control and prevention initiatives. For example, the World Economic Forum, a non-governmental organization based in Switzerland, revealed in 2023 that infections like influenza and respiratory syncytial virus (RSV) have seen an uptick since the onset of the pandemic. As of February 2023, it was estimated that in the USA, influenza was responsible for about 24 million illnesses, 260,000 hospitalizations, and 16,000 deaths. Furthermore, in 2022, according to the World Health Organization, there were 10.6 million global tuberculosis infections, resulting in 1.3 million deaths. Therefore, the propagation of communicable diseases is a significant factor in the advancement of the gene editing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp
#What is the Anticipated CAGR of theGene Editing Market, and What Factors Will Drive It?
The market size for gene editing has experienced rapid expansion in recent years. It is projected to increase from $8.82 billion in 2024 to $10.34 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.3%. This surge during the historical period can be traced back to the development of the crispr-cas9 technology, advances in genetic sequencing, innovative medical discoveries, funding for scientific research, and the flourishing biotechnology sector.
In the coming years, the gene editing market is predicted to undergo rapid expansion, with expectations to reach a value of $20.79 billion in 2029, reflecting a compound annual growth rate (CAGR) of 19.1%. The predicted growth during the anticipated period can be credited to factors such as the progress of therapeutic applications, advancements in precision and efficiency, the commercialization of gene therapy, the unfolding of agricultural applications, as well as the expansion of regenerative medicine. Forecasted trends for this period encompass multiplex editing methods, advancements in base editing, gene drives and population alteration, non-viral delivery systems, along with disease simulation and drug discovery.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486
What Key Market Trends and Innovations Are Shaping the Future of theGene Editing Industry?
Leading businesses in the gene editing market are striving to gain a competitive edge by introducing cutting-edge technology, such as the use of cell-penetrating peptides, which offers potential benefits over existing methods. This innovation could promote the creation of sophisticated cell therapies for treating various diseases, including cancer. In April 2023, for instance, Penn Medicine, a principal multi-hospital healthcare system in the US, discovered that viruses’ protein fragments could effectively and safely transport CRISPR-Cas gene editing molecules into cells and their DNA-rich nucleus. The newly developed technique, the researchers believe, could be instrumental in modifying T cells and other patient-derived cells to create new cell therapies. One such application could be CAR T (chimeric antigen receptor T cell) therapy, a treatment method that uses the patient’s genetically engineered immune cells to combat cancer. This novel genetic engineering approach to cell manipulation can potentially enhance speed, efficiency, and decrease cellular toxicity vis-à-vis existing procedures.
Which Companies Are Leading the Charge in Expanding theGene Editing Market Growth?
Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report
How is the Global Gene Editing Market Segemented?
The gene editing market covered in this report is segmented –
1) By Technology: CRISPR, TALEN, ZFN
2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering
3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization
Subsegments:
1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives
2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits
3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp
Which Geographics are Influencing the Growth of the Gene Editing Market?
North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Gene Editing Market 2025, By The Business Research Company:
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
Pharmaceutical Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
Endoscopy Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
